
Diabetic Retinopathy
Latest News
CME Content







ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation








New research confirms agreement with 7 standard field imaging

FDA decision changes scope of healthcare delivery; increases patient access to early detection of DR

Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.



Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.

The prevalence of visual impairment and blindness caused by diabetic retinopathy is increasing worldwide. Early recognition, perhaps via a screening programme, and timely management would be of benefit.


Patients with diabetic retinopathy have a high risk of developing macular edema after cataract surgery. Intravitreal injections of aflibercept might result in fewer patients developing macular edema in this patient population.

Ultra-widefield imaging has become an important component of a thorough eye exam and is taking on a larger role in retina and comprehensive ophthalmology.
















































